Our Services
Medical Information
Helpful Resources
Published on: 6/13/2026
RSV (respiratory syncytial virus) usually causes mild, cold-like symptoms in healthy adults, but it can lead to serious complications such as bronchiolitis, pneumonia, or worsening of COPD, heart failure, and other chronic conditions. High-risk groups include older adults, people with lung or heart disease, immunocompromised individuals, and pregnant women.
Recommended treatment includes rest, hydration, and over-the-counter symptom relief, along with close monitoring of fever, breathing rate, and oxygen levels. Severe cases may require antiviral medication or hospital care. Prevention strategies include RSV vaccination, frequent handwashing, and avoiding contact with sick individuals.
Because RSV symptoms often mimic the flu, COVID-19, or a common cold—and because early identification of high-risk warning signs can change outcomes—it's worth taking a few minutes to clarify what you're dealing with. A free, instant, online symptom check can help you understand your symptoms, gauge your risk level, and decide whether home care or a doctor's visit is the right next step.
Reviewed for medical accuracy: 2026-06-13
Respiratory syncytial virus (RSV) is best known as a common childhood infection, but it can affect adults too. In most healthy adults, RSV causes mild, cold-like illness. However, certain groups face a higher risk for severe disease. Understanding RSV symptoms in adults, who's at risk, and how doctors recommend managing and preventing serious complications can help you stay informed and take timely action.
RSV is a contagious virus that infects the respiratory tract. It spreads through:
Once inside your body, RSV multiplies in the lining of your nose, throat, and airways, leading to inflammation and typical respiratory symptoms.
RSV symptoms in adults often resemble a common cold or mild flu. They usually appear 4–6 days after exposure and can include:
Most adults recover in 1–2 weeks. However, RSV can worsen underlying lung or heart conditions, leading to more severe presentations.
While RSV can cause discomfort in anyone, these groups face higher risk for complications:
In these populations, RSV can lead to pneumonia, bronchitis, or exacerbations of existing conditions.
Most healthy adults experience a self-limited illness. But in high-risk individuals, RSV can escalate into:
Hospitalization may be required if breathing becomes difficult or if oxygen levels drop.
Contact your healthcare provider if you experience:
Early medical evaluation is key for people at higher risk of severe disease.
If you're experiencing respiratory symptoms and want to understand whether they could be RSV or require medical attention, try Ubie's Medically approved LLM Symptom Checker Chat Bot—a free, AI-powered tool that helps you assess your symptoms and determine your next steps for care.
Even if your symptoms are mild, you can pass RSV to vulnerable people. To protect family and friends:
Always reach out to a healthcare professional if you have any of the following:
Any of these could signal a life-threatening situation. If symptoms become severe, call emergency services or go to the nearest emergency department.
Staying informed and proactively managing RSV can help you recover more comfortably and prevent spread to others. Take simple precautions, monitor your health, and don't hesitate to seek medical advice when needed.
(References)
* Zucchelli A, et al. Risk factors for severe respiratory syncytial virus infection in older adults: a systematic review. Clin Infect Dis. 2022 Jul 15;75(2):323-333. doi: 10.1093/cid/ciab1009. Epub 2021 Dec 14. PMID: 34907931.
* Zang Y, et al. The burden of respiratory syncytial virus infection in adults: A systematic review and meta-analysis. J Clin Virol. 2022 Sep;158:105342. doi: 10.1016/j.jcv.2022.105342. Epub 2022 Sep 10. PMID: 36099839.
* Kulkarni U, et al. Respiratory syncytial virus in adults: a review of clinical presentation, diagnosis, management, and prevention. Ther Adv Infect Dis. 2023 Jan 30;10:20499361231154744. doi: 10.1177/20499361231154744. PMID: 36798030; PMCID: PMC9907106.
* Simões EAF, et al. Strategies for the prevention and management of respiratory syncytial virus infection in adults. Curr Opin Infect Dis. 2022 Apr 1;35(2):154-162. doi: 10.1097/QCO.0000000000000827. PMID: 35165187.
* Palacios G, et al. Respiratory Syncytial Virus Infection in Adults: What We Know and What We Still Need to Know. Vaccines (Basel). 2023 Dec 15;11(12):1915. doi: 10.3390/vaccines11121915. PMID: 38131362; PMCID: PMC10747447.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.